QUALITYCARE

EUIPO EUIPO 2012 Application refused

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark QUALITYCARE was filed as Word mark on 07/04/2012 at the European Union Intellectual Property Office. The current status of the mark is "Application refused".

Trademark Details Last update: October 22, 2018

Trademark form Word mark
File reference 011015047
Application date July 4, 2012

Trademark owner

Industriparken, 55
2750 Ballerup
DK

Trademark representatives

Industriparken, 55 2750 Ballerup DK

goods and services

5 Pharmaceutical preparations for the treatment of cancer and dermatological, hematological, renal and endocrine disorders; powders, talcum powders, creams, lotions, gels, foundation and lip balm for the treatment of dermatological disorders, cancer and skin infections; glues for medical use; medical and wound dressings; dressings for the treatment of dermatological disorders, cancer and skin infections
41 Providing educational and training services (gymnastic instruction), including, conducting classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; educational services in the field of treatment of cancer and dermatological, hematological, renal and endocrine disorders; education services, including, providing on-line classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; arranging and conducting of lectures in the field of cancer and dermatological, hematological, renal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line electronic publications (not downloadable), including, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; publication of electronic books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing online educational and informational games in the field of cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof
42 Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and dermatological, hematological, renal and endocrine disorders; conducting clinical trials for pharmaceutical products in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing information about the results of clinical trials for pharmaceutical products; providing online software applications containing information on the use of pharmaceutical products and for calculating use of medicine
44 Providing medical information, consultancy and advisory services; medical and pharmaceutical consultation; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical counseling; medical services, including, medical care in the field of cancer and dermatological, hematological, renal and endocrine disorders; planning of medical treatment programs for the treatment of cancer and dermatological, hematological, renal and endocrine disorders; providing information and advice in the fields of cancer and dermatological, hematological, renal and endocrine disorders; providing a web site featuring medical information; hygienic and beauty care
45 Personal and social services rendered by others to meet the needs of individuals, including, providing non-therapeutic counseling and emotional support to patients and families of patients, and providing information to relatives on how to provide emotional support to patients and families of patients

ID: 11011015047